| Serial Number | 98081069 |
| Word Mark | TT |
| Filing Date | Wednesday, July 12, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, December 31, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 21, 2025 |
| Description of Mark | The mark consists of an abstract design in the color light blue, within which is a white upside down letter T on top of a white right side up letter T. |
| Goods and Services | Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collecting, analyzing and organizing data in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data |
| Goods and Services | Pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical and biological pharmaceutical preparations for medical purposes, namely, for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; immunotherapeutic drugs namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes |
| Pseudo Mark | T THERAPEUTICS |
| Indication of Colors claimed | The color(s) light blue and white is/are claimed as a feature of the mark. |
| Goods and Services | Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories |
| Goods and Services | Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 10, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 10, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 10, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | T-Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB216AL GB |
| Event Date | Event Description |
| Saturday, July 15, 2023 | NEW APPLICATION ENTERED |
| Thursday, August 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 11, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, March 20, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, March 27, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, March 27, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, March 27, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, March 27, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 27, 2024 | CORRESPONDENCE E-MAILED |
| Friday, May 31, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, May 31, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, May 31, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 11, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 11, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 11, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 11, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, July 11, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 11, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 9, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, October 9, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, November 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 16, 2024 | FINAL REFUSAL WRITTEN |
| Monday, December 16, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, December 16, 2024 | FINAL REFUSAL E-MAILED |
| Friday, December 27, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, December 27, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 27, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Friday, December 27, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 27, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |